tiprankstipranks
Trending News
More News >

Roy Buchanan Profile - Citizens JMP Analyst

39 Followers
tipranks
Roy Buchanan

Roy Buchanan
Citizens JMP

Wall Street Analyst
#9,601 out of 10,113 Wall Street Analysts
#35,356 out of 42,320 experts

Success Rate

35%
85 out of 246 ratings made a profit

Average Return

-5.90%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Roy Buchanan's trades since 2015 and holding each position for 1 Year would result in 34.55% of your transactions generating a profit, with an average return of -5.9% per rating.

Stock Rating Distribution

327Ratings
94.19% Buy
5.81% Hold
0.00% Sell
Distribution of Roy Buchanan's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United States

Best Rating

Stock:
Cidara Therapeutics Inc.
(CDTX)
Rating:Buy
Date:Jun 02, 2025 - Today
Return:+800.00%
The most profitable rating made by Roy Buchanan

Roy Buchanan's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
MRTX
Mirati Therapeutics
Jun 01, 2015
Buy
Reiterated
1Ratings
0%
-32.50%
Corcept Therapeutics
Dec 16, 2015
Buy
Initiated
$8.00
(-89.92% Downside)
1Ratings
100%
+76.30%
Geron
Dec 16, 2015
Buy
Initiated
$6.50
(450.85% Upside)
1Ratings
0%
-54.60%
vTv Therapeutics
Dec 16, 2015
Buy
Initiated
$21.00
(-21.35% Downside)
1Ratings
0%
-18.20%
XLRN
Acceleron Pharma
Feb 29, 2016
Buy
Upgraded
2Ratings
100%
+5.40%
Aldeyra Therapeutics
Feb 29, 2016
Buy
Reiterated
$25.00
(356.20% Upside)
3Ratings
33%
-17.03%
Amicus
Mar 08, 2016
Buy
Upgraded
$12.00
(20.85% Upside)
2Ratings
0%
-6.10%
Advaxis
May 17, 2016
Buy
Reiterated
$22.00
(14754.83% Upside)
2Ratings
50%
-13.55%
Eledon Pharmaceuticals
Jul 26, 2016
Hold
Downgraded
2Ratings
0%
-85.80%
Sangamo Biosciences
Aug 04, 2016
Hold
Downgraded
3Ratings
0%
-37.50%
List of latest recommendations made by Roy Buchanan. Click to expand and see Roy Buchanan's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Roy Buchanan activity FAQ

What is the performance of Roy Buchanan's recommendations?
The percentage of profitable recommendations made by Roy Buchanan is 35%, and the average return per transaction is -5.90%.
    What stocks does Roy Buchanan cover?
    Roy Buchanan mostly covers ENTA ,ABUS ,PYPD stocks.
      What was Roy Buchanan's most profitable rating?
      Roy Buchanan’s most profitable ratings was a buy on CDTX stock on Jun 02, 2025 - Today. The return on the trade was +800.00%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here